-
Heart failure today is the focus of enormous growth of interest in research, clinical trials, and improved care. A number of factors are responsible for the increasing prominence of congestive heart failure (CHF).
-
DFT reassessment after the institution of antiarrhythmic drug therapy with amiodarone or sotalol is not routinely required.
-
What is the role of raloxifene for the treatment of osteoporosis and breast cancer prevention? Raloxifene is a selective estrogen-receptor modulator similar to tamoxifen.
-
-
Rescue PCI in the setting of early fibrinolytic failure improves mortality, but this is tempered by a possible increase in the risk of thromboembolic stroke.
-
Even a device which makes perfect physiological sense may not help us achieve the goals of improved outcomes for out-of-hospital cardiac arrest victims.
-
Commonly used drugs in patients with coronary disease or COPD may be beneficial in the absence of specific guideline recommendations at present.
-
Do long-acting beta agonist inhalers increase the severity of asthma? Yes, according to the results from a large meta-analysis recently published in the Annals of Internal Medicine.
-
Although time to reperfusion is correlated with mortality in ST elevation myocardial infarction (STEMI) treated with fibrinolytics, its importance in patients treated with percutaneous coronary interventions (PCI) is less clear.
-
